After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NYSE listed company, DBD falls under the Technology sector while operating within the Software – Application industry segment. The current market capitalization of Diebold Nixdorf Inc is $2.47B. A total of 92472.0 shares were traded on the day, compared to an average of 197.95K shares.
In the most recent transaction, Millstreet Capital Management sold 211,204 shares of DBD for 62.93 per share on Nov 05 ’25. After the transaction, the 10% Owner now owns 5,757,194 company shares. In a previous transaction on Nov 06 ’25, Millstreet Capital Management sold 40,522 shares at 64.52 per share. DBD shares that 10% Owner owns now total 5,716,672.
Among the insiders who sold shares, Millstreet Capital Management disposed of 38,963 shares on Sep 18 ’25 at a per-share price of $60.08. This resulted in the 10% Owner holding 5,968,398 shares of DBD after the transaction. In another insider transaction, Millstreet Capital Management sold 20,000 shares at $60.11 per share on Sep 16 ’25. Company shares held by the 10% Owner now total 6,007,361.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, DBD has a high of $69.23 and a low of $34.88.
As of this writing, DBD has an earnings estimate of $1.65 per share for the current quarter. EPS was calculated based on a consensus of 3.0 estimates, with a high estimate of $1.73 per share and a lower estimate of $1.51. The company reported an EPS of $0.99 in the last quarter
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. DBD’s latest balance sheet shows that the firm has $423.20M in Cash & Short Term Investments as of fiscal 2021. There were $2.45B in debt and $1.75B in liabilities at the time. Its Book Value Per Share was $29.47, while its Total Shareholder’s Equity was -$837.00M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DBD is Buy with a score of 4.50.
